Acquiring Company
CNR Research
Acquired Company
EPS International Korea Ltd
South KoreaSouth KoreaBiotechnologyPharmaceuticalConsultingBiotechnologyHealth CarePharmaceuticalDescription
CNR Research has acquired EPS International Korea Ltd. to enhance its clinical trial network in Northeast Asia. This acquisition aims to leverage EPSI Korea's capabilities to connect with Japanese pharmaceutical companies. CNR Research plans to expand its cross-border CRO business, focusing on joint clinical trials. The deal positions CNR Research as a key player in multi-regional clinical trials in Asia.
Quick answer
CNR Research is acquiring EPS International Korea Ltd, announced July 13, 2026. CNR Research is based in South Korea.
- How much did CNR Research pay for EPS International Korea Ltd?
- The deal value was not disclosed.
- What does CNR Research do?
- CNR Research is a global contract research organization (CRO) specializing in clinical development services.
- Where are CNR Research and EPS International Korea Ltd based?
- CNR Research is based in South Korea. EPS International Korea Ltd is based in South Korea.
- Who are the decision-makers at CNR Research?
- Fundz holds 2 contacts at CNR Research. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Consulting
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Tarsus Pharmaceuticals to acquire Alkeus Pharmaceuticals (August 6, 2026)
- Supernus to merge with Indivior Pharmaceuticals (August 3, 2026)
- Tarsus acquires iRenix Medical for IRX-101 development (July 8, 2026)
- Jagsonpal Pharmaceuticals acquires Aequitas Healthcare (June 30, 2026)
- Cencora integrates COR clinical services acquisition (June 29, 2026)
- GSK to acquire Nuvalent for $10.6 billion, $11B (June 9, 2026)
Who to call at CNR Research, and when
When CNR Research changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day CNR Research raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CNR Research, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CNR Research. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CNR Research makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired EPS International Korea Ltd?
EPS International Korea Ltd was acquired by CNR Research, based in South Korea. The deal was reported on July 13, 2026. CNR Research is a global contract research organization (CRO) specializing in clinical development services. CNR Research is privately held and operates in Biotechnology.
When did CNR Research acquire EPS International Korea Ltd?
CNR Research's acquisition of EPS International Korea Ltd was reported on July 13, 2026. CNR Research has acquired EPS International Korea Ltd. to enhance its clinical trial network in Northeast Asia. This acquisition aims to leverage EPSI Korea's capabilities to connect with Japanese pharmaceutical companies. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does EPS International Korea Ltd do?
EPS International Korea Ltd. is a subsidiary of Japan's EPS Group, which is a leading contract research organization (CRO) in Japan. Established in 1991, the parent company has been involved in a significant proportion of Japan's new drug applications. It is privately held, operating in Biotechnology, and is based in South Korea.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.